cGAS-mediated inflammation has been recognized to be at the root of a multitude of diseases, ranging from systemic rheumatological conditions, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), to organ-specific pathologies such as myocardial infarction (MI). This evidence concerns the gene CGAS and rheumatoid arthritis.